Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation

Abstract

Background The gut microbiota was shown to play a crucial role in the development of vascular dysfunction, and the bacterial composition differed between healthy controls and coronary artery disease patients. The goal of this study was to investigate how the gut microbiota affects host metabolic homeostasis at the organism scale. Methods We colonized germ-free C57BL/6 J mice with faeces from healthy control donors (Con) and coronary artery disease (CAD) patients and fed both groups a high fat diet for 12 weeks. We monitored cholesterol and vascular function in the transplanted mice. We analysed bile acids profiles and gut microbiota composition. Transcriptome sequencing and flow cytometry were performed to evaluate inflammatory and immune response. Results CAD mice showed increased reactive oxygen species generation and intensive arterial stiffness. Microbiota profiles in recipient mice clustered according to the microbiota structure of the human donors. Clostridium symbiosum and Eggerthella colonization from CAD patients modulated the secondary bile acids pool, leading to an increase in lithocholic acid and keto-derivatives. Subsequently, bile acids imbalance in the CAD mice inhibited hepatic bile acids synthesis and resulted in elevated circulatory cholesterol. Moreover, the faecal microbiota from the CAD patients caused a significant induction of abnormal immune responses at both the transcriptome level and through the enhanced secretion of cytokines. In addition, microbes belonging to CAD promoted intestinal inflammation by contributing to lamina propria Th17/Treg imbalance and worsened gut barrier permeability. Conclusions In summary, our findings elucidated that the gut microbiota impacts cholesterol homeostasis by modulating bile acids. In addition, the CAD-associated bacterial community was shown to function as an important regulator of systemic inflammation and to influence arterial stiffness.

Hormone Replacement Therapy Reverses Gut Microbiome and Serum Metabolome Alterations in Premature Ovarian Insufficiency

“…The abundance of Eggerthella is increased in patients with Rett syndrome, and it induces alterations in short-chain fatty acids profiles ( 29 ). Colonization of Eggerthella in patients with coronary artery disease resulted in increased circulating cholesterol levels ( 30 ). The alteration of lipid metabolites in POI with respect to Eggerthella is unclear.…”

Evaluating Causal Relationship Between Metabolites and Six Cardiovascular Diseases Based on GWAS Summary Statistics

“…The metabolic pathway analysis found multiple disease-associated metabolic pathways; for instance, it was shown that "Bile Acid Biosynthesis" was related to CAD, which was consistent with the prior finding. Recent evidence suggested that inhibition of liver bile acid synthesis can lead to elevated serum cholesterol levels in a highfat diet, which in turn affected the development of CAD (Liu et al, 2020). Meanwhile, in observational studies, the serum total bile acids of CAD patients were lower than those of non-CAD patients, and the lower concentration of total bile acids was independently and significantly correlated with the presence and severity of CAD (Li et al, 2020b).…”

Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer

“…The ratio of primary/secondary BAs depends on the situation. For healthy people, the ratio in the duodenal fluid is about 5 to 6 [109,110], the ratio in feces is around 4, with primary BAs accounting for 80% [111] and the ratio of DCA metabolites to CA metabolites in serum is close to 5 [112]. However, for patients with colorectal cancer or polyps, the proportion of secondary BAs significantly increased [113], especially the LCA.…”